370 related articles for article (PubMed ID: 34951356)
1. Drug Delivery Systems and Strategies to Overcome the Barriers of Brain.
Garg Y; Kapoor DN; Sharma AK; Bhatia A
Curr Pharm Des; 2022; 28(8):619-641. PubMed ID: 34951356
[TBL] [Abstract][Full Text] [Related]
2. Nose-to-brain delivery of nanotherapeutics: Transport mechanisms and applications.
Xu K; Duan S; Wang W; Ouyang Q; Qin F; Guo P; Hou J; He Z; Wei W; Qin M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1956. PubMed ID: 38558503
[TBL] [Abstract][Full Text] [Related]
3. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
[TBL] [Abstract][Full Text] [Related]
4. In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route.
Ghosh A; Majie A; Karmakar V; Chatterjee K; Chakraborty S; Pandey M; Jain N; Roy Sarkar S; Nair AB; Gorain B
AAPS PharmSciTech; 2024 May; 25(5):96. PubMed ID: 38710855
[TBL] [Abstract][Full Text] [Related]
5. Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose-Brain Drug Delivery.
Taha E; Shetta A; Nour SA; Naguib MJ; Mamdouh W
Mol Pharm; 2024 Mar; 21(3):999-1014. PubMed ID: 38329097
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Islam SU; Shehzad A; Ahmed MB; Lee YS
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318
[TBL] [Abstract][Full Text] [Related]
7. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
Pardeshi CV; Belgamwar VS
Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
[TBL] [Abstract][Full Text] [Related]
8. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
[TBL] [Abstract][Full Text] [Related]
9. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
10. Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review.
Babu SR; Shekara HH; Sahoo AK; Harsha Vardhan PV; Thiruppathi N; Venkatesh MP
Ther Deliv; 2023 Sep; 14(9):571-594. PubMed ID: 37691577
[TBL] [Abstract][Full Text] [Related]
11. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
Phukan K; Nandy M; Sharma RB; Sharma HK
Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles for direct nose-to-brain delivery of drugs.
Mistry A; Stolnik S; Illum L
Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine for Intranasal Delivery to Improve Brain Uptake.
Patel AA; Patel RJ; Patel SR
Curr Drug Deliv; 2018; 15(4):461-469. PubMed ID: 29034836
[TBL] [Abstract][Full Text] [Related]
14. Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.
Du L; Chen L; Liu F; Wang W; Huang H
Int Rev Neurobiol; 2023; 171():255-297. PubMed ID: 37783558
[TBL] [Abstract][Full Text] [Related]
15. Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis.
Mwema A; Muccioli GG; des Rieux A
J Control Release; 2023 Dec; 364():435-457. PubMed ID: 37926243
[TBL] [Abstract][Full Text] [Related]
16. Strategies for drug delivery to the central nervous system by systemic route.
Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
[TBL] [Abstract][Full Text] [Related]
17. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.
Selvaraj K; Gowthamarajan K; Karri VVSR
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2088-2095. PubMed ID: 29282995
[TBL] [Abstract][Full Text] [Related]
18. Drug delivery systems from nose to brain.
Misra A; Kher G
Curr Pharm Biotechnol; 2012 Sep; 13(12):2355-79. PubMed ID: 23016642
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in drug delivery and targeting to the brain.
Sethi B; Kumar V; Mahato K; Coulter DW; Mahato RI
J Control Release; 2022 Oct; 350():668-687. PubMed ID: 36057395
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicines for intranasal delivery: understanding the nano-bio interactions at the nasal mucus-mucosal barrier.
Hua T; Li S; Han B
Expert Opin Drug Deliv; 2024 Apr; 21(4):553-572. PubMed ID: 38720439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
